EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Reduced Vancomycin Susceptibility in Clostridioides difficile Is Associated With Specific Ribotypes

Taryn A Eubank iD, Chetna Dureja iD, Anne J Gonzales-Luna iD, Julian G Hurdle iD, Kevin W Garey iD

Open Forum Infectious Diseases · 30.10.2024 · 11 (11)

DOI: 10.1093/ofid/ofae588 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Open Forum Infectious Diseases, online erschienen am 10.10.2024. Verfasst von Taryn A Eubank und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Practice and Translational Research, University of Houston College of Pharmacy, Houston, Texas, USA. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Reduced vancomycin (VAN) susceptibility in clinical Clostridioides difficile isolates is correlated with poor clinical outcomes. However, factors associated with infection with these strains are unknown. The goal of this study was to determine risk factors for reduced VAN susceptibility among clinical isolates of C. difficile.

Methods

This multicenter cohort study included adults with C. difficile infection (CDI) between 2016 and 2021. Clinical C. difficile isolates underwent agar dilution VAN susceptibility testing and ribotyping. Reduced susceptibility was defined as a minimum inhibitory concentration (MIC) > 2 µg/mL. Medical charts were reviewed for host, pathogen, and hospital characteristics and assessed for predictors of reduced VAN susceptibility.

Results

Five hundred and ninety-four hospitalized patients with CDI between 2016 and 2021 (female: 57%, age >65 years: 55%, White/non-Hispanic: 59%, nonsevere CDI episode: 53%) were identified. Of 594 isolates, 173 (29%) had reduced VAN susceptibility (MIC50: 2 µg/mL, MIC90: 4 µg/mL). In multivariable analysis, ribotype (RT) 027 (odds ratio [OR]: 13.4; 95% confidence interval [CI], 7.7–23.4; P < .0001) and RT 255 (OR: 2.9; 95% CI, 1.4–6.1; P = .005) were positively associated with reduced VAN susceptibility whereas RT 014–020 (OR: 0.41; 95% CI, 0.21–0.80; P = .0092) was more likely to be susceptible to VAN. The prevalence of strains with reduced VAN susceptibility increased over time (P = .0163). No patient- or hospitalization-specific variable predicted infection with reduced susceptibility strain.

Conclusions

Certain ribotypes, including RT 027, were the sole independent risk factors for reduced VAN susceptibility. Increased clinical surveillance of these strains, especially RT 027, and their antibiotic susceptibly is warranted to inform prescribing practices.

Schlagwörter

Stichwörter der Autor:innen

Clostridioides difficileanaerobesantimicrobial resistancerisk factorsvancomycin

Autor:innen und Institutionen

  • Department of Pharmacy Practice and Translational Research, University of Houston College of Pharmacy, Houston, Texas, USA.
  • Center of Infectious and Inflammatory Diseases, Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston, Texas, USA.

ORCID-Profile: Taryn A Eubank, Chetna Dureja, Anne J Gonzales-Luna, Julian G Hurdle, Kevin W Garey

Förderung

  • NIAID NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • National Institutes of Health
  • American College of Clinical pharmacy Foundation Junior Investigator Research
  • Society of Infectious Diseases Pharmacists Early Career Research

Zitieren

APA

Eubank, T. A., Dureja, C., Gonzales-Luna, A. J., Hurdle, J. G., & Garey, K. W. (2024). Reduced Vancomycin Susceptibility in Clostridioides difficile Is Associated With Specific Ribotypes. Open Forum Infectious Diseases, 11(11). https://doi.org/10.1093/ofid/ofae588

Vancouver

Eubank TA, Dureja C, Gonzales-Luna AJ, Hurdle JG, Garey KW. Reduced Vancomycin Susceptibility in Clostridioides difficile Is Associated With Specific Ribotypes. Open Forum Infectious Diseases. 2024;11(11). doi:10.1093/ofid/ofae588

BibTeX
@article{Eubank2024,
  author = {Eubank, Taryn A and Dureja, Chetna and Gonzales-Luna, Anne J and Hurdle, Julian G and Garey, Kevin W},
  title = {Reduced Vancomycin Susceptibility in Clostridioides difficile Is Associated With Specific Ribotypes},
  journal = {Open Forum Infectious Diseases},
  year = {2024},
  volume = {11},
  number = {11},
  doi = {10.1093/ofid/ofae588}
}
Kostenlos starten →